International Cannabis Weekly: 113

• Germany receives first medical cannabis imports from Portugal and Australia.
• DEA to triple quotas for medical cannabis research.
• Indian government authorises the country’s first medical cannabis research project.

• German medical cannabis market generates €13.3 million in taxes in 2018.
• British cannabis company Cannaray secures £7.8 million in Series A funding.
• Spanish firms looking to capitalise on cannabis market potential, despite illegality.
• Recent poll suggests 47% of Scots support cannabis legalisation.
• Israeli cannabis industry slowing due to lack of established regulation.
• French parliament to hold a debate on the benefits of medical cannabis.
• UK alternative finance community to gather at Cannabis Finance Forum next Tuesday.

The European market is open for business. As international markets begin to develop we’re bringing together key innovators, investors and operators from either side of the Atlantic. For the first time, we are coming to Toronto, on November 5th, and New York, on November 7th. Join the debate.

Book tickets now

• Paraguay to begin awarding medical cannabis licences.
• Mexico’s congress to create a regulatory framework for recreational cannabis.
• Jamaica’s cannabis market dependent on US banking legislation.
• Colombia’s cannabis industry is aiming to compete in the global market.

• Former NZ Prime Minister supports legal cultivation licences for black-market growers.
• Myanmar to legalise the industrial cultivation of hemp.
• Bhumjaithai party in Thailand to present two amendments to draft Narcotics Act.
• Melbourne cannabis company is supplying cannabis to 1,925 patients.

• South Africa considers expunging cannabis-related crimes from citizen records.
• Lesotho leading the African medical cannabis industry.

• Medical cannabis sales in Arkansas surpass US$8 million in first four months.
• Ohio rejects autism and anxiety as qualifying conditions for medical cannabis.
• Alabama lawmakers reject the medical value of cannabis.
• More US companies receive federal warning letters over CBD health claims.

• Study suggests heavy regulations on cannabis facilitate illicit market growth.
• Study shows cannabis can reduce symptoms of anxiety, depression and stress.

Prohibition Partners is proud to launch The North American Cannabis Report, the most in-depth analysis of the Canadian and US cannabis markets. We would like to take this opportunity to thank all those who helped to support the production of this report. Download your free copy now.

Download